Ignite Creation Date:
2024-05-05 @ 10:48 PM
Last Modification Date:
2024-10-26 @ 10:24 AM
Study NCT ID:
NCT01196767
Status:
COMPLETED
Last Update Posted:
2013-04-04
First Post:
2010-07-26
Brief Title:
Ropivacaine Though Laterosternal Catheters After Cardiac Surgery
Sponsor:
University Hospital Clermont-Ferrand
Organization:
University Hospital Clermont-Ferrand
Study Overview
Official Title:
Postoperative Analgesia After Cardiac Surgery Effects of a Continuous Infusion of Ropivacaine Through Laterosternal Catheters
Status:
COMPLETED
Status Verified Date:
2013-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective double-blinded and randomised study involving patients undergoing cardiac surgery with median sternotomy the effects on postoperative analgesia of a 48-hr continuous infusion of ropivacaine 2 mgmL-1 at the rate of 4 mLhr-1 through two catheters inserted at the lateral edges of the sternum will be studied versus a control group in which normal saline will be infused in the same conditions
Detailed Description:
Diverse methods for infusion of local anaesthetics after cardiac surgery have been proposed but none of them provided high-level evidence of efficacy The catheters studied here are designed for a surgical insertion before closure of the sternotomy with the aim of infusing the drug the closest possible of the terminations of intercostal nerves
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None